ERBB4 and amyotrophic lateral sclerosis: It was found that the inhibition of NRG1-ErbB4 signaling was a key factor which might influence the incidence of ALS, and activation ErbB4 using NRG1 or its agonist might be a potential therapeutic strategy for ALS treatment [37].